ADVANCED LIVER FIBROSIS
Clinical trials for ADVANCED LIVER FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED LIVER FIBROSIS trials appear
Sign up with your email to follow new studies for ADVANCED LIVER FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Low-Dose erlotinib aims to stop liver cancer before it starts
Prevention Not yet recruitingThis phase II trial tests whether a low dose of the cancer drug erlotinib can prevent liver cancer in 60 adults with advanced liver fibrosis or cirrhosis. Participants will take either erlotinib or a placebo daily for a set period. The study will measure changes in a blood protei…
Matched conditions: ADVANCED LIVER FIBROSIS
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC
-
Could a simple scan and blood test outsmart liver cancer?
Knowledge-focused Not yet recruitingThis study looks at whether a structured surveillance program using regular ultrasound and a blood test (alpha-fetoprotein) can detect liver cancer at an earlier, more treatable stage in people at high risk. About 300 adults with liver cirrhosis, chronic hepatitis B, or advanced …
Matched conditions: ADVANCED LIVER FIBROSIS
Sponsor: D'Or Institute for Research and Education • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC